Sonoace, the German distributor of the Korean firm Medison Co. Ltd has launched its first hand carried ultrasound machine MySono U5 at Medica. ‘Complete with various image optimisation processing technologies in a lightweight and compact form , Mysono U5 is designed to guarantee immediate diagnostics in a wide range of applications, such as emergency medicine, vascular, musculoskeletal and…
The new Isolette 8000 is the latest model in Dräger’s respected Isolette series of infant incubators that introduced innovations such as the patented Dual Air Curtain, known from the Isolette C2000. ‘This thermal management capability, which is also part of the Isolette 8000, reduces radiant heat loss from the infant and contributes to a cocoon-like environment, where the neonate can…
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, according to Nobel Prize winner, Professor Emeritus Harald zur Hausen (University of California, San Diego) after recently delivering a keynote lecture at the 16th International Meeting of the European Society of…
ECCO 15 – ESMO 34, the joint congress of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO), is Europe’s largest oncology meeting; the event drew to Berlin 15,000 participants from 120 countries this September, when more than 2,000 presentations were made. Among the presentations on prevention, treatment and survivorship, proteomics, biomarkers,…
Sonoace, the German distributor for Medison Co. Ltd, has announced the launch of a new, dedicated high performance OB/GYN ultrasound system, the ACCUVIX V20 ‘Prestige’, which features the industry's first multi-rendering 3-D/4-D technology, 3-D MXI (3-D Multi-eXtended Imaging ).
Designed for multi-applications (e.g. general imaging, obstetrics/gynaecology, abdomen, small parts, musculoskeletal, urology, vascular) MyLab 20Plus, manufactured by Esaote Biomedica Deutschland GmbH, can be customised to suit individual needs in a shared ultrasound department or clinic.
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, predicted Nobel Prize winner, Professor Harald zur Hausen, after delivering the key-note lecture at the 16th International Meeting of the European Society of Gynaecological Oncology (ESGO) in Belgrade, Serbia,…
Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
In 2006, 4.3 million children were born in US hospitals; of these, 158,000 mothers and infants (3.5%) sustained injuries that could have been avoided. For comparison purposes, newly published US statistics could prove interesting for European hospital administrators, says Dot M McSherry of i.t. Communications
The fact that child diabetics (type I) in Russia do not receive necessary and qualitative therapy was again highlighted during the 7th Russian conference 'The priority national project - Health - and the tasks of children's endocrinologists' held in Saint-Petersburg this June.
Robot-assisted surgery can be used to successfully repair abnormal openings between the uterus and the bladder, according to a report by Ashok K. Hemal, M.D., a Wake Forest University Baptist Medical Center urologist who is the world's most experienced surgeon in the procedure.
In the Forbes China report this year, Edan is not only listed in the ‘Top 200 Chinese Enterprise with the Best Growing Potential´ (ranking 17th), but also this unlisted company's rapid rise on the score table made it the Forbes China star, being named as the Best Mover of Year 2008.
During KIMES, Karoline Laarmann (European Hospital) met with Joong-Ho Lee, Senior Executive Vice President of the ultrasound systems manufacturer MEDISON, the Korean firm that entered the ultrasound market in the 1980s and quickly established a global reputation for innovative developments (e.g. the firm produced the first commercial real-time 3-D ultrasound scanner).
Every year the German Society for Senology congress facilitates interdisciplinary breast cancer discussion between gynaecologists, radiologists, surgeons, pathologists, internists, radio-oncologists and plastic surgeons. In an interview with Karoline Laarmann, of European Hospital, radiologist Professor Ingrid Schreer (right), head of the Breast Centre at the University Women's Hospital in Kiel,…
Tuttlingen Municipal Clinic occupies two sites, the result of merger in 2002 of two clinics in Tuttlingen and Spaichingen, following a merger of the two clinics in Tuttlingen and Spaichingen in 2002.
Uterine fibroids are the most common benign tumours in women. Treatment is only necessary if the fibroids cause pain and bleeding due to their size and position. Minimally-invasive fibroid embolisation is a gentle, efficient and long-lasting treatment for their removal, leaving the uterus intact. The first evaluations of several international long-term studies have indicated a high success rate…
17-21 March Stockholm Sweden
Working in partnership to integrate diagnostic imaging, laboratory diagnostics and IT, the Hospital Clinic Barcelona and Siemens Healthcare aim to develop innovative systems to prevent, treat and follow-up for various pathologies.
This was not a quick birth. The concept began back in 1963. After finishing each day's work at the Women's Hospital, Dusseldorf, obstetrician Konrad Hammacher spent his nights at the Medical Academy, toiling over an idea.
There is now new hope for women around the world, with the launch of an early detection test for ovarian cancer, according to HealthLinx Limited. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.
The Anthony Nolan Trust Cord Blood Bank and combined research institute, opened in September at Nottingham Trent University, will store stem cells from the blood of newborn babies' umbilical cords as part of a multi-million pound project that aims to bank 50,000 cord bloods.
Vulvar cancer is the fourth most common cancer of the female genital tract. In 2008, roughly 3,460 cases of vulvar cancer will be diagnosed in the United States and about 870 will die of this cancer, according to the American Cancer Society.
Almost 25 years ago Michael Harrison of the University of California, San Francisco (UCSF) operated on the bladder of an unborn child. Almost eight years later, surgery was carried out on the diaphragm of an unborn child. His approach was controversial: a paediatric surgeon opened the abdomen and uterus of the pregnant woman, lifted out the foetus, performed the surgery and returned the foetus to…
The future of the in vitro diagnostics (IVD) market looks promising. According to a new analysis from Frost & Sullivan, Western European IVD Market is estimated to reach $12.65 billion in 2014. The reason: Diseases depending on an aging population, such as infections, hike the demand for automated diagnostic tools.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Now a molecular genetics research team around Prof Naama Barkai found out that an inhibitor molecule channels the morphogenic substances within the injured embryo so that new growing tissues and organs are developing in the right proportions.